Sales decline 29.79% to Rs 60.79 crore
Net profit of Balaxi Pharmaceuticals rose 65.13% to Rs 13.59 crore in the quarter ended December 2023 as against Rs 8.23 crore during the previous quarter ended December 2022. Sales declined 29.79% to Rs 60.79 crore in the quarter ended December 2023 as against Rs 86.58 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales60.7986.58 -30 OPM %22.4717.67 -PBDT13.1110.71 22 PBT12.6310.53 20 NP13.598.23 65Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
